SEGMENT INFORMATION - Research and development (Details) - USD ($) |
6 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| SEGMENT INFORMATION | ||
| Total research and development expenses | $ 13,964,667 | $ 12,015,184 |
| Single reportable segment | ||
| SEGMENT INFORMATION | ||
| Direct research and development expenses | 5,575,874 | 3,940,166 |
| Payroll and other related costs of personnel | 6,773,495 | 6,340,610 |
| Lab supplies and other research and development expenses | 1,615,298 | 1,734,408 |
| Total indirect research and development expenses | 8,388,793 | 8,075,018 |
| Total research and development expenses | $ 13,964,667 | $ 12,015,184 |
| X | ||||||||||
- Definition Amount of expense for research and development directly attributable to clinical trials, cost to develop product candidates and cost specific to project. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development not specific to a program and consists of personnel costs, maintenance and other related activities to multiple projects. No definition available.
|
| X | ||||||||||
- Definition Amount of cost incurred for lab supplies and other research and development expense. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|